logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

Ribociclib+letrozole downstages high-risk HR+ early breast cancer in phase 2

CORALLEEN trial suggests potential for chemo-free strategy.